Published in Oncotarget on September 08, 2015
Air pollution, UV irradiation and skin carcinogenesis: what we know, where we stand and what is likely to happen in the future? Postepy Dermatol Alergol (2017) 0.75
Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol (2008) 6.41
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci (2003) 5.73
Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells. J Am Chem Soc (2004) 3.92
Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer (2006) 3.19
Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl (2006) 3.17
Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc (2005) 2.89
Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc (2005) 2.80
siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl (2007) 2.61
Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules. Nano Lett (2008) 2.51
Protein microarrays with carbon nanotubes as multicolor Raman labels. Nat Biotechnol (2008) 2.08
Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett (2008) 2.01
Multiplexed multicolor Raman imaging of live cells with isotopically modified single walled carbon nanotubes. J Am Chem Soc (2008) 1.65
Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol (2010) 1.38
Applications of Carbon Nanotubes in Biotechnology and Biomedicine. J Biomed Nanotechnol (2005) 1.34
Hyperthermic intraperitoneal chemotherapy: Rationale and technique. World J Gastrointest Oncol (2010) 1.29
Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol (2011) 1.26
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomedicine (2009) 1.25
Cell engineering and cultivation of chinese hamster ovary (CHO) cells. Curr Pharm Biotechnol (2010) 1.24
Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials (2006) 1.08
Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma. Cancer Treat Res (2007) 1.03
Cytotoxic assessment of carbon nanotube interaction with cell cultures. Methods Mol Biol (2011) 1.02
Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem (2011) 1.01
Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol (2010) 1.00
Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol (2010) 0.98
CT mimics of peritoneal carcinomatosis. Indian J Radiol Imaging (2010) 0.94
Investigation of interactions between poly-L-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiation. Int J Nanomedicine (2010) 0.93
Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol (2012) 0.91
Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. Int J Nanomedicine (2013) 0.90
Identification and analysis of CD133(+) melanoma stem-like cells conferring resistance to taxol: An insight into the mechanisms of their resistance and response. Cancer Lett (2013) 0.89
HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol (2012) 0.89
Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol (2013) 0.89
Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity. Neoplasia (2006) 0.88
Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence. Curr Pharm Des (2012) 0.88
Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol (2013) 0.87
Nanotechnology-mediated targeting of tumor angiogenesis. Vasc Cell (2011) 0.85
Complications related to hyperthermia during hypertermic intraoperative intraperitoneal chemiotherapy (HIPEC) treatment. Do they exist? Eur Rev Med Pharmacol Sci (2012) 0.84
Imaging the distribution of individual platinum-based anticancer drug molecules attached to single-wall carbon nanotubes. Nanomedicine (Lond) (2009) 0.83
Development of a nanocrystalline Paclitaxel formulation for HIPEC treatment. Pharm Res (2012) 0.82
Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int J Nanomedicine (2014) 0.82
Altered Mucins (MUC) trafficking in benign and malignant conditions. Oncotarget (2014) 0.82
Multi-platform genotoxicity analysis of silver nanoparticles in the model cell line CHO-K1. Toxicol Lett (2013) 0.81
Peritoneal carcinomatosis 2011; it's about time for chemosurgery. J BUON (2011) 0.80
Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. Eur J Surg Oncol (2001) 0.80
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer. Oncotarget (2015) 0.80
Magnetic nanoparticles: prospects in cancer imaging and therapy. Discov Med (2007) 0.79
Removal of internal caps during hydrothermal treatment of bamboo-like carbon nanotubes and application of tubes in phenol adsorption. J Colloid Interface Sci (2012) 0.79
Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in Mainland China. World J Gastroenterol (2011) 0.79
Peritonectomy HIPEC-contemporary results, indications. Chin J Cancer Res (2013) 0.78
Patient derived cell culture and isolation of CD133⁺ putative cancer stem cells from melanoma. J Vis Exp (2013) 0.77
Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis. Eur J Surg Oncol (2013) 0.77
Nanoparticle delivery for metastatic breast cancer. Nanomedicine (2012) 0.77
Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol (2013) 0.77
Can hyperthermic intraperitoneal chemotherapy efficiency be improved by blocking the DNA repair factor COP9 signalosome? Int J Colorectal Dis (2014) 0.77
New application of carbon nanotubes in haemostatic dressing filled with anticancer substance. Biomed Pharmacother (2014) 0.77
Surgical treatment of peritoneal carcinomatosis: current treatment modalities. Langenbecks Arch Surg (2013) 0.76
Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines. J Inorg Biochem (2004) 0.76
Palliative interventions in patients with peritoneal metastases and malignant bowel obstruction. J Clin Oncol (2012) 0.76
Modern diagnostic and treatment regimens are needed to achieve the best cancer and quality of life control. Cent European J Urol (2014) 0.76
Carboplatin and sodium butyrate, separate--yes, but combined--never. Acta Pol Pharm (2013) 0.76
Drug targeting systems for cancer therapy: nanotechnological approach. Mini Rev Med Chem (2015) 0.76
Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles. J Skin Cancer (2013) 0.76
Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine. J Inorg Biochem (2012) 0.76
[Modern biomaterials as hemostatic dressings in kidney nephron sparing surgery (NSS)--murine model. A preliminary report]. Polim Med (2012) 0.75
A first case report of rare synchronous double cancers: malignant cutaneous melanoma and gastrointestinal stromal tumor. Postepy Dermatol Alergol (2017) 0.75